midpage
Projects
Sign in to see your projects.
555 F.Supp.3d 932
N.D. Cal.
2021
Read the full case

Background

  • Plaintiffs (three Direct Purchasers — Martinez, McGee, Flannery; multiple Indirect Purchasers and Indirect Resellers) allege Juul Labs, Inc. (JLI) and Altria entered an agreement (culminating in Altria's 35% equity investment) that included a non‑compete/related commitments that caused Altria to withdraw its competing MarkTen Elite product, harming competition in the closed‑system e‑vapor market.
  • Plaintiffs assert federal (Sherman Act §§1,2; Clayton Act §7) and related state antitrust and consumer protection claims; they seek damages and injunctive/declaratory relief; DPPs brought claims against two JLI directors (Pritzker, Valani).
  • JLI moved to compel arbitration and strike class claims based on website Terms and Conditions (T&C) containing an arbitration clause and class‑action waiver presented during account creation (sign‑in wrap with a clickbox inserted after Aug 9, 2018).
  • Court found the post‑Aug 9, 2018 sign‑in process produced sufficient constructive assent to compel arbitration for the three named DPPs, enforced the arbitration/class waiver but severed a one‑year limitations provision as substantively unconscionable.
  • The court held the arbitration covers claims against JLI and the two director defendants (nonsignatories) and granted leave to the DPPs to amend to substitute a representative not bound by the T&C; it stayed effect for 30 days and required plaintiffs to elect stay vs dismissal of those arbitrable claims.
  • On motions to dismiss, the court (a) denied dismissal of most federal antitrust claims (finding plaintiffs plausibly alleged a per se agreement/unlawful restraint and antitrust injury), (b) dismissed certain equitable/injunctive claims for lack of pleaded future injury (leave to amend), (c) dismissed DPP injunctive claims and Section 7 claims against the director defendants with prejudice, and (d) dismissed UCL and some unjust enrichment claims insofar as plaintiffs must plead inadequacy of legal remedies (leave to amend).

Issues

Issue Plaintiff's Argument Defendant's Argument Held
Enforceability of JLI website arbitration & class‑waiver DPPs: they did not actually see or read T&C; no assent JLI: post‑Aug 9, 2018 clickbox + proximate hyperlinked T&C gave constructive assent Enforceable as to the three named DPPs who created accounts after Aug 9, 2018; arbitration compelled; one‑year SOL severed
Procedural/substantive unconscionability of arbitration DPPs: adhesive, surprise, shortened SOL, forum and discovery limits, JLI retained right to court injunctions JLI: typical consumer T&C; lack of negotiation alone insufficient; discovery and forum provisions not oppressive Mostly not unconscionable; one‑year SOL substantively unconscionable and severed; remaining provisions enforced
Binding nonsignatory directors to arbitration DPPs: directors acted for personal enrichment and not as JLI agents; thus not bound Defs: agency/ordinary contract principles bind agents/officers to signatory arbitration clauses Directors Pritzker and Valani bound by arbitration because claims arise from acts taken as JLI agents; arbitration covers claims against them
Adequacy of antitrust pleadings (per se agreement, antitrust injury) Plaintiffs: alleged unwritten agreement and writings + conduct show Altria agreed to exit market, causing supracompetitive prices, reduced output/innovation Defs: written agreements did not expressly force exit; market data (Wells Fargo) shows JLI prices/output fell; alternative benign explanations (regulatory pressure, IP protection) Plaintiffs plausibly alleged a per se agreement and antitrust injury at pleading stage; dismissal denied on merits; future‑injury allegations for equitable relief must be added
Clayton Act §7 claims against Altria, JLI, and directors Plaintiffs: Altria was an actual (or actual‑potential) competitor; acquisition foreclosed re‑entry and reduced competition; JLI can be defendant as seller/asset acquirer Defs: Altria had already exited by closing; JLI didn't acquire stock; directors acquired no assets so cannot be §7 defendants §7 claim against Altria and JLI survived; §7 claims against director defendants dismissed with prejudice
State law claims, UCL and unjust enrichment Plaintiffs: state claims track federal claims and seek restitution; remedies at law may be inadequate Altria: state claims are derivative, captions improperly ask for damages, unjust enrichment requires Altria to have received benefit; remedies at law available State claims generally survive with caveats: UCL/unjust enrichment under several states dismissed for lack of allegation that legal remedies are inadequate (leave to amend); some service‑and‑jurisdiction procedural issues cured by leave to serve/amend

Key Cases Cited

  • Nguyen v. Barnes & Noble, 763 F.3d 1171 (9th Cir. 2014) (internet contract formation; constructive/inquiry notice standard for browsewrap/sign‑in wrap agreements)
  • Colgate v. JUUL Labs, Inc., 402 F. Supp. 3d 728 (N.D. Cal. 2019) (prior JUUL decision addressing conspicuity of website T&C and enforceability)
  • Meyer v. Uber Techs., Inc., 868 F.3d 66 (2d Cir. 2017) (sign‑in wrap enforcement where warning and hyperlinks were conspicuous)
  • Armendariz v. Found. Health Psychcare Servs., Inc., 24 Cal.4th 83 (Cal. 2000) (procedural and substantive unconscionability framework; balancing test)
  • Baltazar v. Forever 21, Inc., 62 Cal.4th 1237 (Cal. 2016) (challenge to enforcement where rules were not attached does not necessarily render arbitration unconscionable)
  • Letizia v. Prudential Bache Sec., Inc., 802 F.2d 1185 (9th Cir. 1986) (nonsignatories may be bound under ordinary contract/agency principles)
  • Somers v. Apple, Inc., 729 F.3d 953 (9th Cir. 2013) (pleading defect where market facts contradicted overcharge theory in antitrust complaint)
  • Knevelbaard Dairies v. Kraft Foods, Inc., 232 F.3d 979 (9th Cir. 2000) (elements of antitrust injury and test for antitrust standing)
  • In re National Football League's Sunday Ticket Antitrust Litig., 933 F.3d 1136 (9th Cir. 2019) (look holistically at interlocking agreements when assessing market effects under rule of reason)
  • DiCarlo v. MoneyLion, Inc., 988 F.3d 1148 (9th Cir. 2021) (public injunctive relief is generally available in arbitration)
Read the full case

Case Details

Case Name: In re Juul Labs, Inc. Antitrust Litigation
Court Name: District Court, N.D. California
Date Published: Aug 19, 2021
Citations: 555 F.Supp.3d 932; 3:20-cv-02345
Docket Number: 3:20-cv-02345
Court Abbreviation: N.D. Cal.
Log In
    In re Juul Labs, Inc. Antitrust Litigation, 555 F.Supp.3d 932